A1 Refereed original research article in a scientific journal

A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-2a as first line treatment in metastatic melanoma

Authors: Vihinen P P, Hernberg M, Vuoristo M-S, Tyynelä K, Laukka M, Lundin J, Ivaska J, Pyrhönen S

Publication year: 2010

Journal: Melanoma Research

Number in series: 4

Volume: 20

Issue: 4

First page : 318

Last page: 325

Number of pages: 8

ISSN: 0960-8931

DOI: https://doi.org/10.1097/CMR.0b013e3283390365